http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010523990-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4718 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010523990-A |
| titleOfInvention | Autoimmune control of prostate cancer by annexin A3 |
| abstract | The present invention relates to a method for diagnosing prostate cancer comprising an autoantibody against Annexin A3 (ANXA3) and / or ANXA3 with a specific reagent. The method allows differentiation from a benign precancer to a malignant state. Furthermore, the method has a prognostic link. |
| priorityDate | 2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.